Table 1.
Overview of sample
| N or mean | % or range SD | |
|---|---|---|
| Studies per yeara | 16.7 | |
| Sample size | 716.14 | 2,123.3 |
| Study design | ||
| Cross-sectional study | 47 | 40.17 |
| Qualitative | 29 | 24.79 |
| RCT | 21 | 17.95 |
| Cohort study | 8 | 6.84 |
| Mix methods | 8 | 6.84 |
| Case report | 3 | 2.56 |
| Case–control study | 1 | 0.85 |
| Priority area | ||
| Public understanding of genetics and genomics | 39 | 33.33 |
| Risk communication | 34 | 29.06 |
| Intervention development and testing | 23 | 19.66 |
| Adequate reach of intervention | 21 | 17.95 |
| New behavioral targets | 0 | 0 |
| Tiers | ||
| Tier 1 | 51 | 43.59 |
| General genetics | 40 | 34.19 |
| Tier 3 | 19 | 16.24 |
| Tier 2 | 7 | 5.98 |
| Located in USA | 82 | 70.09 |
| Funding type | ||
| Government | 57 | 48.72 |
| Not listed | 26 | 22.22 |
| International | 16 | 13.68 |
| Nongovernment | 15 | 12.82 |
| Institutional funding | 3 | 2.56 |
a2018 studies were only included through October 2018. Average number of studies per year was calculated based on seven full years, including all of 2018.